| Product Code: ETC9520188 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
3.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
3.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.8 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about genetic disorders and the importance of genetic screening in Suriname |
4.2.2 Growing demand for advanced healthcare technologies and services in the region |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals proficient in preimplantation genetic screening technology in Suriname |
4.3.2 High initial setup costs and ongoing maintenance expenses associated with implementing PGS technology in healthcare facilities |
5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Trends |
6 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By Types |
6.1 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Screening, 2021- 2031F |
6.1.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021- 2031F |
6.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.2.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fluorescence in Situ Hybridization, 2021- 2031F |
6.2.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.2.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Single-Nucleotide Polymorphism, 2021- 2031F |
6.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By Product and Services |
6.3.1 Overview and Analysis |
6.3.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.3.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Maternity Centers, 2021- 2031F |
6.4.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fertility Clinics, 2021- 2031F |
6.4.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Hospitals, Diagnostic Labs, 2021- 2031F |
6.4.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Service Providers, 2021- 2031F |
6.4.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.7 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.5.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By X-linked Diseases, Embryo Testing, 2021- 2031F |
6.5.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Aneuploidy Screening, 2021- 2031F |
6.5.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.5.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Other, 2021- 2031F |
6.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2021- 2031F |
6.6.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By IVF Prognosis, 2021- 2031F |
6.6.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Late Onset Genetic Disorders, 2021- 2031F |
6.6.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Inherited Genetic Disease, 2021- 2031F |
6.6.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Preimplantation Genetic Screening (PGS) Technology Market Import-Export Trade Statistics |
7.1 Suriname Preimplantation Genetic Screening (PGS) Technology Market Export to Major Countries |
7.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Imports from Major Countries |
8 Suriname Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
8.1 Number of healthcare facilities in Suriname offering preimplantation genetic screening services |
8.2 Adoption rate of PGS technology among fertility clinics and hospitals in Suriname |
8.3 Average waiting time for patients to undergo preimplantation genetic screening procedures |
9 Suriname Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
9.1 Suriname Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Suriname Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
9.4 Suriname Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Suriname Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 Suriname Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
10.1 Suriname Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2024 |
10.2 Suriname Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here